Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma

Clinical trial NCT00634452 · COMPLETED

Trial details

NCT number: NCT00634452
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin's Lymphomas

Start date: 2008-02-01
Primary completion: 2010-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.